P2 purinergic receptor modulation of cytokine production.

Purinergic Signalling
Christopher A Gabel

Abstract

Cytokines serve important functions in controlling host immunity. Cells involved in the synthesis of these polypeptide mediators have evolved highly regulated processes to ensure that production is carefully balanced. In inflammatory and immune disorders, however, mis-regulation of the production and/or activity of cytokines is recognized as a major contributor to the disease process, and therapeutics that target individual cytokines are providing very effective treatment options in the clinic. Leukocytes are the principle producers of a number of key cytokines, and these cells also express numerous members of the purinergic P2 receptor family. Studies in several cellular systems have provided evidence that P2 receptor modulation can affect cytokine production, and mechanistic features of this regulation have emerged. This review highlights three separate examples corresponding to (1) P2Y₆ receptor mediated impact on interleukin (IL)-8 production, (2) P2Y₁₁ receptor-mediated affects on IL-12/23 output, and (3) P2X₇ receptor mediated IL-1β posttranslational processing. These examples demonstrate important roles of purinergic receptors in the modulation of cytokine production. Extension of these cellular observations to in vivo s...Continue Reading

References

Apr 3, 1992·Science·D P CerrettiL A Cannizzaro
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·K A HogquistD D Chaplin
Mar 1, 1995·The Journal of Clinical Investigation·S FalzoniF Di Virgilio
Jan 1, 1994·Annual Review of Immunology·P A Baeuerle, T Henkel
Sep 1, 1993·The American Journal of Physiology·G R Dubyak, C el-Moatassim
Feb 3, 1997·The Journal of Experimental Medicine·D FerrariF Di Virgilio
Apr 1, 1997·British Journal of Pharmacology·C E Gargett, J S Wiley
Nov 19, 1997·Neuropharmacology·G ColloG Buell
Nov 19, 1997·Neuropharmacology·D FerrariF Di Virgilio
Feb 12, 1998·British Journal of Pharmacology·C E GargettJ S Wiley
Feb 12, 1998·The New England Journal of Medicine·A D Luster
Apr 16, 1998·British Journal of Pharmacology·J JinS P Kunapuli
Jul 1, 1998·International Reviews of Immunology·C A Dinarello
Dec 9, 1998·The American Journal of Physiology·D G Perregaux, C A Gabel
Dec 16, 1998·FEBS Letters·I P ChessellP P Humphrey
May 1, 1999·The Journal of Biological Chemistry·D FerrariK Schulze-Osthoff
Aug 10, 1999·European Journal of Pharmacology·B R BianchiT van Biesen
Sep 14, 1999·British Journal of Pharmacology·C B GrahamesP P Humphrey
Oct 3, 1999·Physiological Reviews·S NarumiyaF Ushikubi
Dec 22, 1999·The Journal of Biological Chemistry·R E LaliberteC A Gabel
Mar 1, 2000·British Journal of Pharmacology·G HaskóC Szabó
Aug 11, 2000·Journal of Neurochemistry·I HideY Nakata
Sep 26, 2000·American Journal of Physiology. Cell Physiology·B J GuJ S Wiley
Oct 4, 2000·The Journal of Biological Chemistry·M SolleC A Gabel
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M SchnurrA Eigler
Nov 30, 2000·The New England Journal of Medicine·J M BathonB K Finck
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D FerrariF Di Virgilio
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R O WilliamsR N Maini
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A la SalaG Girolomoni

❮ Previous
Next ❯

Citations

Feb 19, 2009·Purinergic Signalling·Matthew W GrolS Jeffrey Dixon
Nov 19, 2009·Purinergic Signalling·Elena Bulanova, Silvia Bulfone-Paus
Jul 28, 2011·Purinergic Signalling·Marek CieślakMichał Komoszyński
Jun 2, 2009·Nature Reviews. Drug Discovery·Matthias GaestelMichael Kracht
Feb 28, 2014·TheScientificWorldJournal·Torben Madsen KvistNiklas Rye Jørgensen
Sep 10, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luiz Anastacio AlvesValber da Silva Frutuoso
Oct 12, 2010·Toxicology·Irena Baranowska-BosiackaLidia Strużyńska
Sep 8, 2010·Neurochemistry International·Tomasz GrygorowiczDorota Sulejczak
Jun 12, 2009·The Journal of Investigative Dermatology·Michael D HowellDonald Y M Leung
Apr 20, 2014·Biochimica Et Biophysica Acta·Hercules Antônio da Silva-SouzaPedro Muanis Persechini
Sep 20, 2012·Clinical & Developmental Immunology·M DolcinoA Puccetti
Jul 19, 2019·JDR Clinical and Translational Research·T H HarrisL M Shaddox
Sep 18, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Elena DolmatovaHeather S Duffy
Jun 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Filip KukulskiJean Sévigny
Dec 1, 2011·Neurologia i neurochirurgia polska·Marek Cieślak, Michał Komoszyński
Dec 16, 2016·Journal of Gastroenterology and Hepatology·Liping WuHiroto Miwa
Jan 29, 2021·Glia·Jennifer Patritti-CramNancy Ratner
Jan 21, 2010·Science Signaling·Axel WeberMichael Kracht

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
lavage

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.